Bariatric surgery: Indications, safety and efficacy

Current Pharmaceutical Design

Volumn 17, Issue 12, 2011, Pages 1209-1217

  Ben David, K ^a   Rossidis, G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Bariatric surgery; Efficacy; Obesity; Safety; Weight loss

Indexed keywords

ACCREDITATION; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ESOPHAGUS INJURY; GASTRECTOMY BILLROTH II; GASTRIC BANDING; GASTROJEJUNAL STRICTURE; GASTROJEJUNOSTOMY; HERNIA; HUMAN; HYPERLIPIDEMIA; IMMUNE COMPLEX DISEASE; INTESTINE STENOSIS; JEJUNOSTOMY; JEJUNUM; KIDNEY DISEASE; KIDNEY FAILURE; LAPAROSCOPIC SLEEVE GASTRECTOMY; LIVER CIRRHOSIS; LIVER FAILURE; MALABSORPTION; MEDICAL SOCIETY; METABOLIC DISORDER; MINIMALLY INVASIVE SURGERY; MORBID OBESITY; MORBIDITY; MORTALITY; NUTRITIONAL DEFICIENCY; OBESITY; OXALIC ACID NEPHROPATHY; PATIENT SAFETY; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; QUALITY OF LIFE; RISK FACTOR; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; SLEEVE GASTRECTOMY; STOMACH BYPASS; STOMACH INJURY; STOMACH ULCER; SURGEON; SURGICAL RISK; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 79958188922     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795656828     Document Type: Article

References (102)

1. World Health Organization [Media centre Homepage]. Geneva, Switzerland: World Health Organization (WHO); c2011. [Updated2006 September; cited 2011 Jan 26]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
2. CDC Vital Signs: State-Specific Obesity Prevalence among Adults;United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:951-955.
3. From June 2010 Prevalence of Obesity Among Children and Adolescents: United States, Trends 1963-1965 Through 2007-2008 by Cynthia Ogden, Ph.D., and Margaret Carroll, M.S.P.H., Division of Health and Nutrition Examination Survey
4. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity,diabetes, and obesity related health risk factors, 2001. JAMA 2003;289: 76-79.
5. Centers for Disease Control and Prevention (CDC). [U.S. ObesityTrends Home Page] Atlanta, GA: Center for Disease Control andPrevention; c2011. [Updated 2011 January 26; cited 2011 January26]. Available from: www.cdc.gov/obesity/data/trends.html
6. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence andtrends in obesity among US adults, 1999-2008. JAMA 2010; 303:235-241.
7. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, KoplanJP. The continuing epidemics of obesity and diabetes in the UnitedStates. JAMA 2001; 286: 1195-1200.
8. Garrow JS. Treat obesity seriously: a clinical manual. Edinburgh:Churchill Livingstone, 1981.
9. Walters RG, Jacquemont S, Valsesia A, et al. A new highlypenetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010; 463: 671-675.
10. Hinney A, Vogel CI, Hebebrand J. From monogenic to polygenicobesity: recent advances. Eur Child Adolesc Psychiatry 2010; 19:297-310.
11. FM DLV, Bustamante CD, Leal SM. Genome-wide associationmapping and rare alleles: from population genomics topersonalized medicine-Session Introduction. Pac Symp Biocomput 2011: 74-75.
12. Kant AK, Graubard BI. Secular trends in patterns of self-reportedfood consumption of adult Americans: NHANES 1971-1975 toNHANES 1999-2002. Am J Clin Nutr 2006; 84: 1215-1223.
13. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437-439.
14. Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010; 39: 1-7.
15. Klesges RC, Shelton ML, Klesges LM. Effects of television onmetabolic rate: potential implications for childhood obesity. Pediatrics 1993; 91: 281-286.
16. Dietz WH, Jr, Gortmaker SL. Do we fatten our children at thetelevision set? Obesity and television viewing in children andadolescents. Pediatrics 1985; 75: 807-812.
17. Dennison BA, Erb TA, Jenkins PL. Television viewing andtelevision in bedroom associated with overweight risk among lowincomepreschool children. Pediatrics 2002; 109: 1028-1035.
18. Holsten JE. Obesity and the community food environment: asystematic review. Public Health Nutr 2009; 12: 397-405.
19. Powell LM. Fast food costs and adolescent body mass index:evidence from panel data. J Health Econ 2009; 28: 963-970.
20. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Televisionwatching and other sedentary behaviors in relation to risk of obesityand type 2 diabetes mellitus in women. JAMA 2003; 289:1785-1791.
21. McTigue K, Larson JC, Valoski A. Mortality and cardiac and vascularoutcomes in extremely obese women. JAMA 2006; 296: 79-86.
22. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB.Years of life lost due to obesity. JAMA 2003; 289: 187-193.
23. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, andmortality in a large prospective cohort of persons 50 to 71 yearsold. N Engl J Med 2006; 355: 763-778.
24. Withrow D, Alter DA. The economic burden of obesity worldwide:a systematic review of the direct costs of obesity. Obes Rev 2010;12: 131-141.
25. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medicalspending attributable to obesity: payer-and service-specificestimates. Health Aff (Millwood) 2009; 28: w822-31.
26. Frezza EE, Wachtel MS. The economic impact of morbid obesity. Surg Endosc 2009; 23: 677-679.
27. Ludwig DS, Pollack HA. Obesity and the economy: from crisis toopportunity. JAMA 2009; 301: 533-535.
28. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Clinical Efficacy Assessment Subcommittee of the American College of Physicians.Pharmacologic and surgical management of obesity in primarycare: a clinical practice guideline from the American Collegeof Physicians. Ann Intern Med 2005; 142: 525-531.
29. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologictreatment of obesity. Ann Intern Med 2005; 142: 532-546.
30. Payne JH, DeWind LT, Commons RR. Metabolic observations inpatients with jejunocolic shunts. Am J Surg 1963; 106: 273-289.
31. Payne JH, De Wind LT. Surgical treatment of obesity. Am J Surg 1969; 118: 141-147.
32. Griffen WO Jr, Young VL, Stevenson CC. A prospective comparisonof gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977; 186: 500-509.
33. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Biliopancreaticbypass for obesity: II. Initial experience in man. Br JSurg 1979; 66: 618-620.
34. Scopinaro N. Biliopancreatic diversion: mechanisms of action andlong-term results. Obes Surg 2006; 16: 683-689.
35. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998; 22: 936-946.
36. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversionfor obesity at eighteen years. Surgery 1996; 119: 261-268.
37. Hess DS, Hess DW. Biliopancreatic diversion with a duodenalswitch. Obes Surg 1998; 8: 267-282.
38. Wiren M. Outcome of laparoscopic duodenal switch for morbidobesity. Br J Surg 2011; 98: 84-85.
39. Mason EE. Gastric surgery for morbid obesity. Surg Clin NorthAm 1992; 72: 501-513.
40. Torres JC, Oca CF, Garrison RN. Gastric bypass Roux-en-Y gastrojejunostomyfrom the lesser curvature. South Med J 1983; 76:1217-1221.
41. Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastricbypass in the super obese: A prospective randomized study. AnnSurg 1992; 215: 387-395.
42. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Rouxen-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000; 10: 233-239.
43. Higa KD, Ho T, Boone KB. Laparoscopic Roux-en-Y gastric bypass:technique and 3-year follow-up. J Laparoendosc Adv SurgTech 2001; 11: 377-382.
44. Kravetz AJ, Reddy S, Murtaza G, Yenumula P. A comparativestudy of handsewn versus stapled gastrojejunal anastomosis inlaparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2010 Oct 7[Epub ahead of print].
45. Parini U, Fabozzi M, Brachet Contul R, Lale Murix E, Millo P. Laparoscopic approach to morbid obesity: personal experience of250 gastric bypasses. Analysis of different techniques and results.Minerva Chir 2007; 62: 83-91.
46. Curley SA, Weaver W, Wilkinson LH. Gastric (reservoir) reductionfor morbid obesity. Arch Surg 1981; 116: 602-605.
47. Kuzmak LI, Thelmo W, Abramson DL. Reversible adjustablegastric banding. Surgical technique. Eur J Surg 1994; 160: 569-571.
48. Catona A, Gossenberg M, La Manna A. Laparoscopic gastric banding:preliminary series. Obes Surg 1993; 3: 207-209.
49. Belachew M, Belva PH, Desaive C. Long-term results of laparoscopicadjustable gastric banding for the treatment of morbid obesity. Obes Surg 2002; 12: 564-568.
50. Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAN Dsystem. Am J Surg 2002; 184: 46S-50S.
51. Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S.Biliopancreatic diversion with a new type of gastrectomy. ObesSurg 1993; 3: 29-35.
52. Silecchia G, Boru C. Effectiveness of laparoscopic sleeve gastrectomy(first stage of biliopancreatic diversion with duodenal switch)on comorbidities in super-obese high-risk patients. Obes Surg 2006; 16: 1138-1144.
53. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, GoldfineA. Serum ghrelin levels in response to glucose load in obesesubjects post-gastric bypass surgery. Obes Res 2003; 11: 919-924.
54. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levelsafter diet-induced weight loss or gastric bypass surgery. N Engl JMed 2002; 346: 1623-1630.
55. US Preventive Services Task Force. Screening for Obesity inAdults: Recommendations and Rationale. Rockville, Md: Agencyfor Healthcare Research and Quality, 2003.
56. American Gastroenterological Association. American Gastroenterology Association medical position statement on Obesity. Gastroenterology 2002; 123: 879-881.
57. NIH conference. Gastrointestinal surgery for severe obesity. ConsensusDevelopment Conference Panel. Ann Int Med 1991; 115:956-961.
58. Buchwald H. Consensus conference statement, bariatric surgery formorbid obesity: health implications for patients, health professionals,and third-party payers. Surg Obes Relat Dis 2005; 1: 317-318.
59. Lindroos AK, Lissner L, Sjostrom L. Weight change in relation tointake of sugar and sweet foods before and after weight reducinggastric surgery. Int J Obes Relat Metab Disord 1996; 20: 634-643.
60. Bueter M, Thalheimer A, Lager C, Schowalter M, Illert B, Fein M.Who benefits from gastric banding? Obes Surg 2007; 17: 1608-13.
61. Lemont D, Moorehead M, Parish M, et al. Suggestions for thepresurgical psychological assessment of bariatric surgery candidates. American Society for Bariatric Surgery 2004.
62. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreaseslong-term mortality, morbidity, and health care use in morbidlyobese patients. Ann Surg 2004; 240: 416-423.
63. Monk JS Jr, Dia Nagib N, Stehr W. Pharmaceutical savings aftergastric bypass surgery. Obes Surg 2004; 14: 13-15.
64. Dixon JB, O'Brien PE. Changes in comorbidities and improvementsin quality of life after LAP-BAND placement. Am J Surg 2002; 184: 51S-54S.
65. Greenway SE, Greenway FL 3rd, Klein S. Effects of obesity surgeryon non-insulin-dependent diabetes mellitus. Arch Surg 2002;137: 1109-1117.
66. Pories WJ, Swanson MS, MacDonald KG, et al. Who would havethought it? An operation proves to be the most effective therapy foradult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350.
67. Adams TD, Gress RE, Smith SC, et al. Long-term mortality aftergastric bypass surgery. N Engl J Med 2007; 357: 753-761.
68. Sjöström L, Narbro K, Sjöström CD, et al. Swedish Obese SubjectsStudy. Effects of bariatric surgery on mortality in Swedish obesesubjects. N Engl J Med 2007; 357: 741-752.
69. Sjöström L, Gummesson A, Sjöström CD, et al. Swedish ObeseSubjects Study. Effects of bariatric surgery on cancer incidence inobese patients in Sweden (Swedish Obese Subjects Study): a prospective,controlled intervention trial. Lancet Oncol 2009; 10: 653-662.
70. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis:surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.
71. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: asystematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
72. Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F. The impact of gastric bypass on gastroesophagealreflux disease in patients with morbid obesity: a prospectivestudy based on the Montreal Consensus. Ann Surg 2010; 251:244-248.
73. Prachand VN, Alverdy JC. Gastroesophageal reflux disease andsevere obesity: Fundoplication or bariatric surgery? World J Gastroenterol 2010; 16: 3757-3761.
74. Karlsson J, Sjöström L, Sullivan M. Swedish obese subjects (SOS)--an intervention study of obesity. Two-year follow-up of healthrelatedquality of life (HRQL) and eating behavior after gastric surgeryfor severe obesity. Int J Obes Relat Metab Disord 1998; 22:113-126.
75. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidenceof diabetes, hypertension and lipid disturbances after intentionalweight loss induced by bariatric surgery: the SOS InterventionStudy. Obes Res 1999; 7: 477-484.
76. Torgerson JS, Sjöström L. The Swedish Obese Subjects (SOS)study--rationale and results. Int J Obes Relat Metab Disord 2001;25: S2-S4.
77. Torgerson JS. The Swedish Obese Subjects (SOS) Study. Whatdoes weight loss really accomplish? MMW Fortschr Med 2002;144: 24-26.
78. Agren G, Narbro K, Näslund I, Sjöström L, Peltonen M. Long-termeffects of weight loss on pharmaceutical costs in obese subjects. Areport from the SOS intervention study. Int J Obes Relat MetabDisord 2002; 26: 184-192.
79. Narbro K, Agren G, Jonsson E, Näslund I, Sjöström L, Peltonen M. Swedish Obese Subjects Intervention Study. Pharmaceutical costsin obese individuals: comparison with a randomly selected populationsample and long-term changes after conventional and surgicaltreatment: the SOS intervention study. Arch Intern Med 2002; 162:2061-2069.
80. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospectivetrial of gastric bypass versus vertical banded gastroplasty formorbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613-624.
81. Hudson SM, Dixon JB, O'Brien PE. Sweet eating is not a predictorof outcome after Lap-Band placement. Can we finally bury themyth? Obes Surg 2002; 12: 789-794.
82. Brolin RE. Long limb Roux en Y gastric bypass revisited. SurgClin North Am 2005; 85: 807-817.
83. Cunneen SA, Phillips E, Fielding G, et al. Studies of Swedishadjustable gastric band and Lap-Band: systematic review and metaanalysis. Surg Obes Relat Dis 2008; 4: 174-185.
84. Chevallier JM, Paita M, Rodde-Dunet MH, et al. Predictive factorsof outcome after gastric banding: a nationwide survey on the roleof center activity and patients' behavior. Ann Surg 2007; 246:1034-1039.
85. Hess DS, Hess DW. Biliopancreatic diversion with a duodenalswitch. Obes Surg 1998; 8: 267-282.
86. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversionwith duodenal switch. World J Surg 1998; 22: 947-954.
87. Ren CJ, Patterson E, Gagner M. Early results of laparoscopicbiliopancreatic diversion with duodenal switch: a case series of 40consecutive patients. Obes Surg 2000; 10: 514-523.
88. Baltasar A, Bou R, Miró J, Bengochea M, Serra C, Pérez N. Laparoscopic biliopancreatic diversion with duodenal switch: techniqueand initial experience. Obes Surg 2002; 12: 245-248.
89. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy asa treatment for the high-risk super-obese patient. Obes Surg 2004;14: 492-497.
90. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience withtwo-stage laparoscopic Roux-en-Y gastric bypass as an alternativein the super-super obese patient. Obes Surg 2003; 13: 861-864.
91. Gagner M, Deitel M, Kalberer TL, Erickson AL, Crosby RD. TheSecond International Consensus Summit for Sleeve Gastrectomy,March 19-21, 2009. Surg Obes Relat Dis 2009; 5: 476-485.
92. Nocca D, Krawczykowsky D, Bomans B, et al. A prospectivemulticenter study of 163 sleeve gastrectomies: results at 1 and 2years. Obes Surg 2008; 18: 560-565.
93. Gluck B, Movitz B, Jansma S, Gluck J, Laskowski K. Laparoscopic Sleeve Gastrectomy is a Safe and Effective Bariatric Procedure for the Lower BMI (35.0-43.0 kg/m(2)) Population. Obes Surg 2010 Dec 3 [Epub ahead of print].
94. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopicsleeve gastrectomy (first stage of biliopancreatic diversion withduodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 2006; 16: 1138-1144.
95. Himpens J, Dapri G, Cadière GB. A prospective randomized studybetween laparoscopic gastric banding and laparoscopic isolatedsleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16:1450-1456.
96. Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-relatedcomorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg 2006; 202: 70-77.
97. Nguyen NT, Paya M, Stevens CM, Mavandadi S, Zainabadi K,Wilson SE. The relationship between hospital volume and outcomein bariatric surgery at academic medical centers. Ann Surg 2004;240: 586-593.
98. Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicarebeneficiaries undergoing bariatric surgical procedures. JAMA 2005; 294: 1903-1908.
99. Birkmeyer NJ, Dimick JB, Share D, et al. Michigan Bariatric SurgeryCollaborative. Hospital complication rates with bariatric surgeryin Michigan. JAMA 2010; 304: 435-442.
100. Pratt GM, Learn CA, Hughes GD, Clark BL, Warthen M, Pories W. Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc 2009; 23: 795-799.
101. Livingston EH. Bariatric surgery outcomes at designated centers ofexcellence vs. non-designated programs. Arch Surg 2009; 144:319-325.
102. DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data fromAmerican Society for Metabolic and Bariatric Surgery-designatedBariatric Surgery Centers of Excellence using the Bariatric OutcomesLongitudinal Database. Surg Obes Relat Dis 2010; 6: 347-355.